American Association of Individual Investors10d
Why ARS Pharmaceuticals, Inc.’s (SPRY) Stock Is Up 19.57%
ARS Pharmaceuticals, Inc.’s SPRY share price has surged by 19.57%, which has investors questioning if this is right time to ...
Benzinga.com11d
ARS Pharmaceuticals Analyst Ratings
The latest price target for ARS Pharmaceuticals (NASDAQ:SPRY) was reported by Scotiabank on March 7, 2025. The analyst firm set a price target for $30.00 expecting SPRY to rise to within 12 months ...